Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Cardiovascular Disease and Chronic Kidney Disease

By sjmartinez • April 28, 2023

Rastogi A, Januzzi JL Jr. Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Cardiovascular Disease and Chronic Kidney Disease. J Clin Med. 2023 Apr 12;12(8):2824. doi: 10.3390/jcm12082824. PMID: 37109162.

Tags: cardiac remodeling, cardiovascular outcomes, Chronic kidney disease, glomerular pressure, heart failure, mechanism of action, Nephrology, Publications, renal outcomes, sodium-glucose cotransporter-2 inhibitors, sympathetic nervous system, Type 2 diabetes

Using a generative co-design framework to adapt an exercise intervention as part of a multimodal intervention for patients’ receiving haemodialysis with or at risk of renal cachexia

Blair C, Slee A, McKeaveney C, Maxwell AP, Awan F, Brown M, Carson M, Comer S, Davenport A, Fogarty D, Fouque D, Gooding O, McKinley[...]

Kassem Safa, MD Appointed Medical Director of the UCLA Kidney Transplant Program

The UCLA Department of Medicine has appointed Kassem Safa, MD, as medical director of the UCLA Kidney Transplant Program in the division of nephrology, effective[...]

A case of adrenal insufficiency after initiation of targeted-release budesonide formulation (Nefecon) in a patient with IgA nephropathy

Laxamana TD, Fervenza FC, Glassock RJ, Zand L. A case of adrenal insufficiency after initiation of targeted-release budesonide formulation (Nefecon) in a patient with IgA[...]